K-Medi Hub, Director Park Gu-seon Inaugurated... "We Will Open the Future of Development and Innovation Together"

Park Gu-seon was inaugurated as the 5th Chairman of K-MEDI Hub (Daegu-Gyeongbuk Medical Innovation Foundation) on the 21st.

Chairman Park Gu-seon held the inauguration ceremony at the foundation's main auditorium on the same day and officially began managing the institution. His term is three years.

Park Gu-seon, Director of K-Medi Hub

At the inauguration ceremony, Chairman Park emphasized "technological innovation" and "ecosystem revitalization." This means that the foundation must strive to trigger open innovation for the convergence and fusion of advanced technologies and to activate the Daegu-Gyeongbuk Advanced Medical Complex, which is the foundation's unique role.

He also did not omit his commitment to transforming the foundation into a talent-centered organization.

Chairman Park pledged to serve as a "windbreaker" that communicates openly with employees, shares concerns, and blocks external disturbances; a "stepping stone" that acts as a bridge where there is water; and a "crucible" that unites efforts for the foundation's vision.

Chairman Park stated, "For the foundation to soar to greater heights, we must move forward with stronger determination than ever before," and expressed his ambition, saying, "I will open the door to tomorrow's development and innovation together with the foundation family."

Chairman Park Gu-seon is well known as a policy planning expert who has worked in the national science and technology field for decades.

Having graduated from high school and university in Daegu, Chairman Park has played key roles at leading domestic research institutions such as the Korea-China Science and Technology Cooperation Center as Chief Representative, the Korea Institute of S&T Evaluation and Planning (KISTEP) as Vice President, and the Korea Institute of Science and Technology (KIST) as a policy research fellow.

In 2018, he served as the 3rd Chairman of the Osong Medical Innovation Foundation, laying the groundwork for the growth of the national bioindustry.

Until recently, Chairman Park led the advancement of national science and technology in the bioindustry while working as a research fellow at KISTEP and a visiting researcher at the Korea Research Institute of Standards and Science (KRISS).

In particular, having overseen global cooperation at KISTEP, he is expected to be a suitable leader for K-MEDI Hub, which emphasizes supporting the global expansion of domestic medical companies.

Given his long experience in policy planning in the science and technology field, there is keen interest in whether the research and development planning at K-MEDI Hub will also expand under his leadership.